The life expectancy of individuals with Duchenne muscular dystrophy has improved considerably with the use of mechanical ventilation to manage respiratory insufficiency. The choice between continuous noninvasive ventilation (NIV) and invasive ventilation is guided both by local logistical considerations and by clinical considerations, but the choice depends largely on patient preference. It is important to know the effects of ventilatory dependence and the method used (ie, continuous NIV or invasive ventilation) on subjects’ quality of life.
METHODS:
This was a cross-sectional prospective survey of 192 subjects with Duchenne muscular dystrophy using mechanical ventilation in France. Subjects were grouped and compared according to dependence on mechanical ventilation and the ventilation methods used.
RESULTS:
Regardless of the mechanical ventilation method, subjects with gastrostomy tubes reported more frequent emergency consultations for digestive problems (22.5% vs 4.6%, P = .001). Subjects with invasive ventilation reported more insomnia than those with continuous NIV (23.8% vs 8.5%, P = .04). The latter reported more ineffective cough than the invasive ventilation group (72.3% vs 49.2%, P = .02). Overall, the subjects in our sample were satisfied with their medical care, regardless of dependence level or ventilation type. More specifically, 86.1% of subjects with intermittent NIV and 83.6% of ventilator-dependent subjects were satisfied.
CONCLUSIONS:
Continuous and invasive mechanical ventilation did not affect the perception of quality of life for our subjects with Duchenne muscular dystrophy, apart from more insomnia, which can be explained by the fact that they required frequent repositioning in bed. Different pressure-relief mattresses should be tested and compared to prevent the development of pressure ulcers, which may improve the sleep patterns of these patients.
EagleM, BaudouinSV, ChandlerC, GiddingsDR, BullockR, BushbyK. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord, 2002; 12(10):926-929.
4.
American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med, 2002; 166(4):518-624.
OgnaA, Quera SalvaMA, PrigentH, MroueG, VaugierI, AnnaneD, et al. Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath, 2016; 20(2):575-581.
7.
BachJR, CampagnoloDI, HoemanS. Life satisfaction of individuals with Duchenne muscular dystrophy using long-term mechanical ventilatory support. Am J Phys Med Rehabil, 1991; 70(3):129-135.
8.
SimondsAK, MuntoniF, HeatherS, FieldingS. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax, 1998; 53(11):949-952.
9.
KohlerM, ClarenbachCF, BöniL, BrackT, RussiEW, BlochKE. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med, 2005; 172(8):1032-1036.
10.
WindischW, FreidelK, SchucherB, BaumannH, WiebelM, MatthysH, PetermannF. Evaluation of health-related quality of life using the MOS 36-Item Short-Form Health Status Survey in patients receiving noninvasive positive pressure ventilation. Intensive Care Med, 2003; 29(4):615-621.
11.
MelliesU, RagetteR, Dohna SchwakeC, BoehmH, VoitT, TeschlerH. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J, 2003; 22(4):631-636.
12.
RobertD, LégerP, GaussorguesP, GérardM. Mechanical ventilation at home by tracheotomy of patients with chronic respiratory insufficiency. Medical conditions of indications and practical modalities of equipment. Rev Prat, 1987; 37(17):1007-1014.
13.
ToussaintM, SteensM, WasteelsG, SoudonP. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J, 2006; 28(3):549-555.
14.
FinderJD, BirnkrantD, CarlJ, FarberHJ, GozalD, IannacconeST, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med, 2004; 170(4):456-465.
15.
BachJR, AlbaAS, SaporitoLR. Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users. Chest, 1993; 103(1):174-182.
16.
BirnkrantDJ, BushbyK, BannCM, AlmanBA, ApkonSD, BlackwellA, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol, 2018; 17(4):347-361.
17.
WindischW, BrambringJ, BudweiserS, DellwegD, GeiselerJ, GerhardF, et al. Nichtinvasive und invasive beatmung als therapie der chronischen respiratorischen insuffizienz.Pneumologie, 2010; 64(4):207-240.
18.
McKimDA, GrillerN, LeBlancC, WoolnoughA, KingJ. Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy. Can Respir J, 2013; 20(1):e5-e9.
19.
BoussaïdG, LofasoF, SantosDB, VaugierI, PottierS, PrigentH, et al. Impact of invasive ventilation on survival when non-invasive ventilation is ineffective in patients with Duchenne muscular dystrophy: a prospective cohort. Respir Med, 2016; 115:26-32.
20.
HessDR. The growing role of noninvasive ventilation in patients requiring prolonged mechanical ventilation. Respir Care, 2012; 57(6):900-918.
21.
VillanovaM, BrancalionB, MehtaAD. Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support. Am J Phys Med Rehabil, 2014; 93(7):595-599.
22.
BachJR. A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver. Chest, 1993; 104(6):1702-1706.
23.
GarguiloM, LerouxK, LejailleM, PascalS, OrlikowskiD, LofasoF, PrigentH. Patient-controlled positive end-expiratory pressure with neuromuscular disease: effect on speech in patients with tracheostomy and mechanical ventilation support. Chest, 2013; 143(5):1243-1251.
24.
TerziN, OrlikowskiD, AegerterP, LejailleM, RuquetM, ZalcmanG, et al. Breathing-swallowing interaction in neuromuscular patients: a physiological evaluation. Am J Respir Crit Care Med, 2007; 175(3):269-276.
25.
TerziN, PrigentH, LejailleM, FalaizeL, AnnaneD, OrlikowskiD, LofasoF. Impact of tracheostomy on swallowing performance in Duchenne muscular dystrophy.Neuromuscul Disord, 2010; 20(8):493-498.
26.
BendittJO, BoitanoLJ. Pulmonary issues in patients with chronic neuromuscular disease. Am J Respir Crit Care Med, 2013; 187(10):1046-1055.
27.
Mier-JedrzejowiczA, BrophyC, MoxhamJ, GreenM. Assessment of diaphragm weakness. Am Rev Respir Dis, 1988; 137(4):877-883.
PrigentH, OrlikowskiD, BlumenMB, LerouxK, LegrandL, LejailleM, et al. Characteristics of tracheostomy phonation valves. Eur Respir J, 2006; 27(5):992-996.
35.
TateD, KirschN, MaynardF, PetersonC, ForchheimerM, RollerA, HansenN. Coping with the late effects: differences between depressed and nondepressed polio survivors. Am J Phys Med Rehabil, 1994; 73(1):27-35.
36.
StuifbergenAK, SeraphineA, HarrisonT, AdachiE. An explanatory model of health promotion and quality of life for persons with post-polio syndrome. Soc Sci Med, 2005; 60(2):383-393.
37.
LueYJ, ChenSS, LuYM. Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men. Disabil Rehabil, 2016:1-6.
38.
RahmanT, SampleW, SeliktarR, ScavinaMT, ClarkAL, MoranK, AlexanderMA. Design and testing of a functional arm orthosis in patients with neuromuscular diseases. IEEE Trans Neural Syst Rehabil Eng, 2007; 15(2):244-251.
39.
GunnM, ShankTM, EppesM, HossainJ, RahmanT. User evaluation of a dynamic arm orthosis for people with neuromuscular disorders. IEEE Trans Neural Syst Rehabil Eng, 2016; 24(12):1277-1283.
40.
ZamaniG, HeidariM, Azizi MalamiriR, AshrafiMR, MohammadiM, Shervin BadvR, et al. The quality of life in boys with Duchenne muscular dystrophy. Neuromuscul Disord, 2016; 26(7):423-427.
